|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/34 | |
| A61P 17/00 | |||
| A61P 17/16 | |||
| A61K 8/64 | |||
| A61Q 17/04 | |||
| A61Q 19/00 |
| (11) | Patento numeris | 2865422 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14173509.2 |
| Europos patento paraiškos padavimo data | 2007-08-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 2006904745 P | 2006-08-31 | AU | |
| 2007900862 P | 2007-02-21 | AU |
| (72) |
Wolgen, Philippe, AU
|
| (73) |
Clinuvel Pharmaceuticals Limited,
Level 6 / 15 Queen Street, Melbourne, VIC 3000,
AU
|
| (54) | Alpha-MSH derivatives for the treatment of photodermatoses |
| Alpha-MSH derivatives for the treatment of photodermatoses |